Skip to main content
Premium Trial:

Request an Annual Quote

Aclara and Iceland Genomics Collaborate on Protein-Biomarker Study

NEW YORK, Dec. 2 (GenomeWeb News) - Iceland Genomics and Aclara BioSciences will collaborate on a cancer biomarker study, the companies said today.

 

Aclara will use its eTag technology to assay tumor and blood samples from cancer patients and from blinded patient data that contain treatment histories and outcomes, collected by Iceland Genomics. Aclara will also pay an undisclosed sum to Iceland Genomics, which will incorporate the data from the study into its database.

 

The research will evaluate proteins and protein complex and functional or activation states in cell-signaling pathways, the companies said.

 

Aclara is  slated to be acquired by ViroLogic sometime before January.